Kevetrin was tested for anti-tumor activity in hu

Kevetrin was tested for anti-tumor activity in human tumor xenograft models using 5 different carcinoma types: lung, breast, colon, prostate, squamous cell carcinomas, and in a leukemia tumor model... In addition, anti-tumor activity was demonstrated in multi-drug resistant tumor models... Kevetrin had greater anti-tumor activity compared to paclitaxel or cisplatin at approximately equitoxic doses despite being less cytotoxic, suggesting that Kevetrin may be targeting specific components of the signal transduction pathway, rather than being simply another cytotoxic agent.

Kevetrin: The "kick'in ass" cancer drug!